Tioga Pharmaceuticals is a company that provides a therapy for the treatment of pruritus. It develops Asimadoline, an orally active kappa-opioid receptor agonist helping to reduce the frequency of scratching induced by intra-dermally injected Substance P. In addition, it helps to inhibit scratching behavior induced by intra-dermally injected histamine or dinitrofluorobenzene.